heumatoid arthritis (RA) 1 is an autoimmune disease that manifests itself in patients with chronic inflammation, synovial proliferation, and progressive joint damage (1) . Several lines of evidence point to a role for T cells in the pathogenesis of RA. These include a genetic predisposition associated with MHC class II genes, whose products function to present antigens to T cells (2) (3) (4) , the presence of activated T cells in inflamed synovial tissues and peripheral blood (5) , and the therapeutic utility of treatments that at least partially inhibit T cell function (6, 7) .
The major population of T lymphocytes that recognize antigen in the context of self-MHC molecules bear the TCR oe/~ heterodimer in association with the CD3 complex (8) . Each chain is divided into a V region that recognizes the Ag/MHC complex and a C region that anchors the molecule to the cell surface. The TCR o~/~ chains are assembled by somatic recombination of discontinuous germline gene 1 Abbreviations used in this paper: EAE, experimental allergic encephalomyelitis; iPCR, inverse polymerase chain reaction; RA, rheumatoid arthritis. segments during T cell development. Polymerization of template-independent N region and template-dependent P nucleotide insertions at the junctions, D~ usage, the imprecise joining of the germline gene segments (selected from a large pool), and the combinatorial association of TCR o~/~ polypeptides help to generate an extensive diversity in the TCR ol/~ repertoire (9) .
During T cell development, only a small fraction of the thymocytes are able to emigrate into the periphery as mature CD4 + or CD8 § T cells. Negative selection events delete self-reactive TCR oe/~-bearing T cells (10, 11) , while positive selection events rescue single-positive CD4 + or CD8 + T cells (12) (13) (14) . Positive selection yields mature CD4 + T cells that are predominantly self-MHC class II restricted or CD8 + T cells that are predominantly self-MHC class I restricted (15) . The binding of antigen peptides to MHC molecules has provided a molecular explanation for the corecognition of Ag/MHC by the TCR ol/B (16) . TCR gene sequences and hypothetical modeling based on Ig molecules suggest that the TCR V regions (especiaUy those regions cot-responding to CDR1 and CDK2) contact the MHC molecule, while the highly diverse V-(D)-Jjunctional region (corresponding to CDR3) contacts antigenic peptides bound to the MHC molecule (9, 17) .
There are strong correlations between TCK V gene usage and T cell antigen recognition specificity in animal studies (18) . Striking T cell repertoire correlations also have been obtained for experimental allergic encephalomyelitis (EAE), an experimental model of autoimmune disease in mice and rats (19) . It has been shown, for instance, that induction and maintenance of the disease is dependent on myelin basic protein-spedfic T cell clones that utilize a restricted pool of Voe, Jc~, and VB gene segments. Since, antigenic specificity in RA is not known, it has been difftcult to establish T cell clones from RA patients to study antigen recognition and TCR V gene usage. The identification of a restricted T cell population based on TCK gene usage in RA might be useful in identifying the relevant autoantigens and offer new therapeutic approaches for this disease.
Here, we used a Voe12.1-specific 6D6 mAb (20) in cell surface staining to identify a subset (17%) of RA patients that showed a striking elevation in the number of Vo~12.1 + ,CD8 + T cells in PBL. Analysis of the Vol12.1 + ,CD8 + T cells in three unrelated individuals by nucleotide sequencing revealed evidence for clonal T cell expansion. Most of the patients with TCR Vo~12.1-elevated CD8 + T cells also shared the HLA-DQ2 phenotype. These results provide evidence suggesting that antigen-driven expansion of T cells may be a component of chronic RA.
Materials and Methods
Immunofluorescence and Flow Cytometry. Flow cytometric analyses were performed using directly conjugated antibodies. Twocolor analyses on PBL were carried out as described previously using a FACScan | (Becton Dickinson & Co., Mountain View, CA) (20) . PBMC was isolated from fresh blood of donors using Ficoll-Hypaque and stained with FITC-conjugated anti-CD4 (OKT4) or anti-CD8 (OKT8) versus PE-conjugated anti-Vow12.1 (6D6) mAbs. Viable cells were analyzed by gating on the propidium iodide-excluding lymphocytes. The following formula was used to calculate the percentage value for Vcr expression on CD4 + and CD8 + subsets: percent V,~12.1+,CD4 + (or Vc~12.1 § +) cells = 100x [Vex12.1 + cells costained with anti-CD4 (or anti-CD8)/percent of total CD4 + (or CD8 § T cells].
Tissue Staining. Samples of synovial membranes were obtained as discarded tissue from surgery, snap-frozen immediately in liquid nitrogen, and stored at -80~ 4-/~m-thick sections were cut and fixed in alcohol-acetone for 10 min at 4~ and stored at -20~ Sections were rehydrated in PBS for 10 min, and two-color fluorescence staining was performed as described previously (21) . Dualcolor fluorescence staining was performed using 6D6-biotin (anti-V,~12.1) mAb and developed with tricolor-coupled streptavidin (Caltag, Paris, France). Tricolor is a two-stage PE-Texas red fluorescent dye excited at 488 nm, with an emission peak at 650 nm. As a second step, samples were stained with commercially available FITC-coupled anti-CD4 or anti-CD8 mAb (Immunotech, Marseilles). Slides were mounted with a drop of Fluoprep medium and sealed. Confocal microscope observations were carried out using an Optiphot fluorescence microscope (Nikon Inc., Instr. Group, Melville, NY) equipped with a confocal head (MKC600; Bio-Rad Laboratories, Richmond, CA) possessing a 488-nm argon laser and two photomultipliers detecting mirror-reflected light (green fluorescence) and the pass-through light (red fluorescence). The two signals were computerized with the Comos software (Bio-Rad Laboratoties), and a photograph was taken with a black-and-white camera. After merging both slides in a 256 optimized color bitmap, a photograph was taken with a color screen photographic device. CD8 + cells are seen in green and Va12.1 + cells are seen in red. The double-stained Vc~12.1 § § T cells are seen in yellow. Polymerase Chain Reaction. Subsets ofT cells were enriched using anti-CD4, anti-CDS, or anti-Vc~12.1 mAbs with magnetic beads (Dynal, Inc., Great Neck, NY). For example, CDS-entiched T cells were isolated by depletion of CD4 § T cells using anti-CD4 mAb and magnetic beads, while CD4-entiched T cells were isolated by depletion of CD8 + T cell using anti-CD8 mAb and magnetic beads. Each of these depleted populations was further subjected to enrichment using anti-Vc~12.1 mAb and magnetic beads. Purification of KNA from these cells was carried out according to Chomczynski and Sacchi (22) . cDNA for the direct PCR method of amplification was synthesized in a reverse transcription reaction using AMV reverse transcriptase, 5 #g of total KNA, and 500 ng of oligo-(dT)12-1s primer before amplification with Vcd2.1-and Col-specific primer combination. For inverse (i)PCK, doublestranded cDNA was synthesized from total KNA (2 #g) and circularized using T4 DNA ligase (23) . Using a pair of C0x or C3 primers oriented in an outward direction from one another, '~700-bp PCK products were generated corresponding to the full-length TCK c~ or 3 chain transcripts (24) . PCR primers were Vcc12.1-specific, 5'~TCGACT'IGCCAGCCTGTTGAGGC~AG; Cc~-specific, 5 'GGGAA~TACAC~_K~AGC~TCAGG; Cc~-forward, 5'GGGTCGACGACCTCATGTCTAGCACAGT; Cc~-inverse, 5'-GCATGCGGCCGCCCTGCTATGCTGTGTGTCT; C3-forward, 5'-GGGTCGACACACAGCGACCTCGGGTGGG; CO-inverse, 5'-GCATGCGGCCGCCATGGTCAAGAGAAAGGA.
Cloning and Sequencing. PCK products were cloned into M13 plasmids and sequenced by the dideoxynucleotide chain termination method using the modified T7 polymerase (Sequenase; United States Biochem. Corp., Cleveland, OH). The sequencing products were resolved on polyacrylamide gels, and autoradiography was cartied out according to standard methods.
Serologic HLA Typing. HLA class I and class II antigens were typed serologically by the Brigham and Women's Hospital Tissue Typing Laboratory (Boston, MA). Serotyping of HLA-A, -B, -C, -DR, and -DQ was performed using standard microcytotoxicity techniques.
Results

VcrI2.1-bearing CD8 + T Cells Are Elevated in Patients with
Reel. The relative percentage of TCR Vo~12.1 on CD4 + or CD8 + T cell subsets in the peripheral blood of RA patients was assessed by two-color fluorescence staining and flow cytometry using the Vc~12.1-specific mAb 6D6 (20) . Analysis of both RA patient (n = 46) and healthy control (n = 68) PBL showed similar frequencies of Vo~12.1 expression by CD4 + T cells (mean, 2.6%; range, 1-4%). Likewise, one group of 38 patients contained percentages of TCR Vcr § T cells in the CD8* subset (mean, 3.6%; range, 1-7%) that were similar to those found in healthy controls. However, a second group of RA patients had elevated percentages of Vo~12.1 + T cells in the CD8 + subset that ex- Fig. 1, V~2.1-elevated) . The elevations of Vot12.1 § T cells was a stable phenomenon since similar values were obtained over a 24-mo period in several of the subjects (data not shown).
Elevated VcrI2.1 + T Cells Are Represented as Clonal or Oligoclonal Expansions. The precise molecular structure of the Vod2.1 + TCR cz chains was determined by cDNA cloning and sequencing from the CD8 + cells purified from three Vc~12.1-elevated patients. PCR products containing Vcd2.1 rearrangements were generated by direct amplification using Vot12.1-and Cot-specific oligonucleotide primers. For each patient a distinct Vcd2.1-containing sequence corresponding to a functional TCR oL chain transcript was repeated extensively (Fig. 2 A) identified two distinct repeated sequences; of these, one sequence accounted for 16 of 24 clones, and the second repeated sequence was identified in 4 of 24 clones. Although the junctional sequences were different in the two repeated Vot12.1 sequences in patient 3, both used the same Jot gene segment, JotA6 (Fig. 2 A) . These results were confirmed using the ilK2K methodology, which utilizes circularized DNA and a pair of ot chain C region oligonucleotide primers oriented away from one another (23, 24) . TCK Vot-containing transcripts were cloned and sequenced from Vot12.t + ,CD8 + T cells purified from PBL. This analysis of patients 1 and 3 revealed the same repeated TCK ot chain sequences that were found with the direct PCR amplifications (Fig. 2 A) . A similar analysis of healthy subjects revealed diverse TCR ot chain sequences with no occurrence of repeated sequences (data not shown). Among the repeated sequences found in the three patients examined, the Vot12.1 was rearranged to distinct Jot gene segments: JotA1, JotA12, and Jo~A6 in patients 1, 2, and 3, respectively. Interestingly, all of these Jot gene segments encode the same amino acid dipeptide sequence (pro-tyr) at their 3' ends ( Fig.  2 A) . Notably, only 6 of the 80 known Jot genes encode this dipeptide sequence, and may constitute a family of functionally related Jot gene segments (25-28; DerSimonian, H., and M. B. Brenner, manuscript in preparation).
We also analyzed the TCR/3 chain transcripts in the purified VOt12.1+,CD8 + T cells using the iPCR methodology. Hence, all potential VB transcripts in Va12.1+,CD8 + T cells from patients I and 3 were cloned and sequenced (Fig.  2 B) . All 18 V/~ cDNA clones in the purified Vot12.1 +, CD8 + T cells were identical in patient 1. Moreover, 12 of 20 eDNA clones from patient 3 were identical but differed from the repeated V/3 sequence identified in patient 1. Since the repeated sequence in patient 3 predicted a VB8-encoded TCR, cell surface coexpression of Votl2.1 and VB8 gene products on CD8 + T cells was demonstrated by flow cytometry using the Vot12.1-specific mAb (6D6) and the VB8-specific mAb (16G8; 29), confirming the molecular cloning results (Fig. 2 C) .
Expanded VoH2.1 + T Cells Carry the "Memory" Phenotype.
Staining of Vot12.1 + T cells with mAb specific to various activation antigens was carried out in two-color flow cytometry analysis as shown for Votl2.1-elevated patient 1 (Fig.  3 A) . Such analyses for patients 1-3 are summarized in histo- gram format (Fig. 3 B) . A majority (>85%) of the expanded peripheral Vot12.1+,CD8 + T cells expressed the memory marker CD45RO +. In addition, 10-30% of these cells expressed detectable levels of VLA-1, an antigen expressed on long-term or chronically activated T cells (35, 36) , HLA-DR antigens, and IL-2R 13 chain. These results are consistent with previous antigen activation and reveal ongoing activation by a fraction of the Vot12.1+,CD8 + peripheral T cells in the Vot12.1-elevated RA patients. They stand in contrast to the lower percentages of CD8 § T cells from healthy subjects expressing these activation markers (Fig. 3 B) . Only percentages of IL-2R ~ chain-bearing cells are similar in normal CD8 + T cells from healthy donors and Vot12.1 +,CD8 + T cells from the RA patients.
Distribution of Voe12.1 +, CD8 + T Cells in the Synovium.
The primary finding in this study is the expansion ofa Vot12.1-bearing CD8 § T cell population in the peripheral blood of a subset of RA patients. Two of these Vc~12.1-elevated patients received a medically indicated joint operation during the course of study allowing analysis of their synovial tissues. Frozen sections were stained for two-color confocal fluorescence microscopy with anti-Vot12.1 mAb 6D6 (red) and anti-CD8 or anti-CD4 mAb (green). Each two-color fluorescent slide was screened for at least 50 cells containing at least five lymphocyte-rich areas (at 240 x). The black-and-white bitmap pictures from each photomultiplier were simultaneously recorded and merged after recoloring. An example of such an evaluation of double-positive (Voe12.1 +,CD8 +) cell staining is shown as the merged product of the CD8 + (top left) and Vc~12.1 + (top right) by scanning of the same field (Fig.  4) . Each double-stained cell is seen in yellow (Vot12.1 +, CDS+), composed of green (CD8 +) and red (Vot12.1 +) color overlap. Synovial membrane staining of the two Vot12.1-elevated patients (nos. 2 and 4) revealed that 8.5 and 10% of CD8 + T cells in their synovial tissue expressed Vot12.1 +, compared with 29 and 27% of their peripheral blood CD8 * T cells, respectively (Table 1) . Thus, the Vce12.1 + ,CD8 + T cells appear to represent a substantial number of the synovial tissue CD8 + T cells, but not as large a fraction as of the peripheral CD8 + T cells. Two Vcd2.1-normal patients (nos. 25 and 46) were also examined and they expressed 3.6 and 6.2% Vo~12.1+,CD8 + cells in their synovial tissues compared with 4.9 and 5.3% in their peripheral blood samples, respectively. Too few synovial tissue analyses from (peripheral) Vot12.1-evaluated donors were made to allow a statistical assessment.
Patients with Expanded Voel2.1 + T Cells Share HLA.DQ2.
The MHC alleles present among the RA patients were analyzed and compared in both the Vot12.1-elevated and Vot12.1-normal groups. As expected, DR1 and DR4 alleles were prominently represented in both groups. Interestingly, the proportion of HLA-DQ2 (which is in strong linkage disequilibrium with DR3 and DR7) was substantially higher among the Vot12.1-elevated versus the Vot12.1-normal group (Fisher's exact test, p = 0.002), as it was found in 7 of 8 (88%) ( Table  2 ) compared with 10 of 38 (26%) patients, respectively. This difference was similar to that of Vot12.1-elevated patients when compared to the expected positivity of 33% in an outbred North American population (X 2 5.05, P <0.025) (37) . While the significance of increased DQ2 frequency for the risk of developing RA is unknown, the donal (or oligoclonal) expansions of Vc~12.1+,CD8 + T cells appear to be more likely in DQ2-positive individuals. Patients in the Vo~12.1-elevated group did not differ clinically, however, from the Vot12.1-normal group with respect to age, sex, duration of disease, rheumatoid factor positivity, erythrocyte sedimentation rates, or arthritis activity measured by number of painful joints and global assessments. 
Discussion
In this study, staining with Vc~12.1-specific mAb and flow cytometry identified a subset of RA patients with elevated numbers of Vo~12.1 + ,CD8 + T cells in the peripheral blood. The molecular analysis revealed that these T ceUs were donaUy (patients 1 and 2) or oligodonaUy (patient 3) expanded, evidenced by TCKs encoded by repeated Vod2.1 gene sequences. The marked expansion in Vc~12.1 + ,CD8 + T cells reported here was detected because fluorescence staining with the Vcx12.1-specific mAb could be readily performed on a large number of subjects with CD4 + and CD8 + T cells analyzed separately. Such screening approaches may be necessary to detect a particular TCK usage phenomenon when it occurs in only a subset of patients. The Vod2.1-elevated patients described here may correspond to an immunologically defined subset even though clinically these patients were similar to the Vcx12.1-normal group. This study, examining the TCK repertoire in RA, differs from other analyses in several aspects (38) . Other studies have predominantly focused on the VB repertoire (39) (40) (41) , performed analyses on the synovial fluid or tissue and on mixtures of both CD4 + and CD8 + T cells (24, (39) (40) (41) (42) (43) (44) , and generally have examined only a few donors (24, (41) (42) (43) . Neverthdess, previous examples of repeated TCKs VB14 and VB17 (as well as VB2, Vfl3, and Vfl13.2 sequences) in synovial fluid or tissue have suggested that donal T cell expansion maybe an important aspect of this disease (40, 41) .
Several examples of restricted Vow, Ja, and VB usage in murine T calls have been reported that characterize a particular T call response to known foreign antigens, for example, Vex11 and Vfl3 in response to cytochrome c (45) (46) (47) protein-induced EAE animal model of autoimmune disease (51) (52) (53) . Thus, a strong antigen-driven activation may cause proliferation of T cell clones that utilize specific Vot, Jc~, and V~ sequences that ultimately dominate as donal (or oligoclonal) populations of circulating T cells in patients with chronic RA. While the mechanism responsible for the clonal Vo~12.1 + T cell expansion in this subset of RA patients is not known, the restricted Vot/Jot usage in unrelated patients and the CD45RO expression by the elevated Vot12.1 + T cells provide support for an antigen-driven activation mechanism. The additional occurrence of the P-Y residues in the Jc~-encoded sequences of these TCKs is another interesting feature of their structure. Preliminary TCK modeling suggests this segment of the Jo~ is near the switch or hinge region that joins the V and C domains. Residues at this site would be unlikely to participate in antigen-MHC recognition, but are predicted to be solvent exposed and might interact with an accessory cellular ligand or impose an effect on TCR c~ chain conformation if this region of the TCK is analogous to the counterpart region in Ig (A. K. Kees, personal communication, University of Bath, UK).
A relationship between HLA-DQ2 and the TCK Vod2.1 + clonal expansion can only be inferred at present. One hy-pothesis would indicate that within the thymus HLA-DQ2 or a closely linked gene might act to select for the individual done, or alternatively HLA-DQ2 might act as the restriction element in presenting antigen to Vod2.1 + T cells in the periphery. It is surprising that the expansion of a CD8 § T cell subset would be associated with the expression of a MHC class II allele since CD8 + T cells generally recognize peptide antigens presented by MHC class I molecules (15) . However, a role for MHC class II and HLA-DQ-encoded molecules in particular in the activation and expansion of CD8 + T cells has been suggested in a number of experimental and clinical conditions where these cells function as regulatory or cytolytic lymphocytes (54) (55) (56) (57) . It is notable that the human antigen-specific T cell clones so far characterized show a bias for HLA-DQ restriction. For example, CD8 + T cell clones derived from blood or lesions of patients with lepromatous leprosy were restricted to HLA-DQ (54) . Alternatively, peptides derived from HLA-DQ molecules may be relevant antigens presented by other HLA molecules. For instance, it has been shown that HLA-B7-derived peptides can be presented by DR11.1 (58) , that HLA-DR3-derived peptides can be presented by HLA-DPw3 (59) , and in a cross-species system HLA-Cw3-derived peptides were presented on murine H-2K a (60) . Further, recent peptide elution experiments from human and mouse MHC molecules have identified numerous peptide sequences encoded by other MHC alleles (61, 62) .
Whether the Vot12.1 + T cell population or the antigen to which it responds are critical to the pathology of the rheumatoid disease process itself remains to be determined. Nevertheless, clonal expansions that account for a mean of 22% of the CD8 + T ceils in the peripheral blood are such large populations numerically that it seems likely that they may have an important functional impact. Since the expansion is in the CD8 + pool of peripheral blood T cdls, these may be a regulatory T cell subset, rather than the predominant proinflammatory T cell in the synovium. Defining this aberration in a subset of patients may have relevance to the diagnosis and treatment of this disease. These clonal T cdl populations together with associated MHC molecules offer newly identified tools to examine specific T cell antigens in this autoimmune disorder of unknown etiology.
